We may earn a commission from provider links, at no added cost to you. Compensation never changes scores; some lists place partners first. Read our affiliate disclosure.
Hims & Hers review
The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.
$149/mo for the Wegovy Pill, medication only
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Hims & Hers at a glance
- Semaglutide
- $149/mo for the Wegovy Pill, medication only
- Tirzepatide
- $299/mo for the Zepbound vial, medication only
- Coverage
- All 50 states
- Start
- "As soon as this week", per its own membership page
How we scored Hims & Hers
Each factor is read off Hims & Hers's published pricing, disclosures and intake flow, and the six roll up into the 69/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Its own membership page says a prescribed plan can be started "as soon as this week", and the catalog and prices are readable before any form. No specific shipping window is published.
The posted figures are all "from" prices covering medication only, with a required $149/month membership billed separately, a $39 teaser first month, and two listings at $1,899 that the page does not explain.
Scored for non-disclosure, not for a known video requirement. Its FAQ asks "Are video visits with a doctor required?" but keeps the answer inside a collapsed panel; the membership model reads asynchronous, with 24/7 messaging and monthly follow-ups.
Long-standing 50-state operator, though its own FAQ question "Are GLP-1s available in all states?" keeps its answer behind an accordion, so the GLP-1 line specifically was not confirmable in this pass.
Both molecules as brand product on one account, in injection and oral form, plus orforglipron as Foundayo — but no compounded option at all, so there is no lower-cost tier to fall back to.
The membership is a standard month-to-month subscription rather than a prepaid term, which is genuinely easier to leave than most of this roster; no cancellation terms were readable on the public pages, so this is not scored higher.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- www.hims.com/weight-loss
Re-read on 26 August 2026 and the catalog has grown again — ten FDA-approved brand listings on one page, including two new oral tablets, the Ozempic Pill and Foundayo. The posted price is only ever half the bill: every single listing carries the same footnote saying the figure is medication only and that a Hims or Hers membership at $39 for the first month, then $149 a month, is billed separately and is required. So the Wegovy Pill at $149 is really about $298 a month and the Zepbound vial at $299 is about $448. Two listings, Mounjaro and one of two Zepbound lines, are posted at $1,899 a month on the same page as Zepbound vials at $299, and the site does not explain the difference. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind.
What to expect when you sign up
We walked Hims & Hers's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Every product tile shows a price and the words "Membership required" before you enter anything — the catalog is genuinely open
- 2Its own published sequence: sign up for the membership at $39 for the first month, answer health questions, a provider reviews the intake, then a plan and, if prescribed, medication
- 3The membership page says you can be started "as soon as this week", and that a smart scale ships separately on opt-in
- 4We read the public catalog, the membership page and the FAQ index and stopped there — no account, no health details entered
What we noticed
- Ten GLP-1 listings on one page, all FDA-approved brand product: Wegovy Pill, Wegovy Pill Microdosing, Wegovy Pen, Zepbound Vial, Zepbound KwikPen, Foundayo Pill, Ozempic Pill, Ozempic, Mounjaro and a second Zepbound line
- Every single one carries the same footnote — the posted price is medication only and the $149/month membership is billed separately
- The $39 first month is explicitly a teaser: "auto-renews at $149/month thereafter"
- Two listings, Mounjaro and one Zepbound line, are posted at a flat $1,899 a month, on the same page as Zepbound vials at $299 — the site does not explain the difference
- The membership carries real content: 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale, a members' community and third-party discounts
- The FAQ page asks "Are video visits with a doctor required?" and "Are GLP-1s available in all states?" but the answers sit inside collapsed accordions and are not in the page text
Pricing
Prices re-verified
These offers have plan commitments, introductory conditions or billing periods that need clarification. See the detailed pricing and terms below and confirm the total due and next charge before paying.
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Hims & Hers's public disclosures at last review and change often; confirm the current number on Hims & Hers's own site.
What we like
- Entirely FDA-approved brand product now — Wegovy, Zepbound, Ozempic, Mounjaro and the new Foundayo tablet, not compounded
- Two oral routes that are FDA-approved rather than compounded: the Wegovy Pill and the new Ozempic Pill, both posted at from $149 a month
- Every price is visible on one open page before you enter anything, each tagged "Membership required" so the structure is not hidden
- The membership carries real content — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and a members' community
- Names its in-house clinicians publicly, including Dr. Craig Primack and, on the Hers side, Dr. Shepherd
- A mature nationwide operator with a real support stack, and it states you can be started as soon as the same week
The caveats
- Every posted price is medication only: a required $149/month membership is billed separately, which roughly doubles the real cost
- The $39 first month auto-renews at $149, so the number you sign up at is not the number you keep paying
- Mounjaro and one of two Zepbound listings are posted at $1,899 a month on the same page as Zepbound vials at $299, with no explanation of the difference
- Its FAQ answers sit inside collapsed panels rather than in the page text, so whether a video visit is required and whether all states are served could not be verified first-hand
- Ozempic and Mounjaro are FDA-approved for type 2 diabetes and the site restricts them to patients meeting those criteria, so they are not a general weight-loss route
- Carries FDA warning letters dated 9 September 2025 — one to Hims & Hers Health, Inc. dba Hims naming hims.com, one to the same company dba Hers — over the prior compounded-semaglutide business, before this pivot to brand-name product
- The broader Hims and Hers catalog nudges upsells into a decision that should be one line long
Hims & Hers for working moms: our verdict
Hims & Hers is best assessed on the total charge, your state eligibility, and how easily you can stop future billing. Hims & Hers does not publish a single standing monthly medication rate. What it does state is "$149/mo for the Wegovy Pill, medication only" — which is not the same thing as a monthly price you can budget against, so treat it as a starting point rather than a total. Before you commit, confirm what the figure covers, which required charges are additional, and how often you will be charged. That is the number to compare against the flat monthly plans elsewhere on this list, which sit near $179/month.
Before choosing Hims & Hers, confirm the prescription offered, the services included, and the renewal terms. The sections below separate those decisions so you can compare the same costs and commitments.
What Hims & Hers will cost you
- Brand-name semaglutide — Wegovy Pill (oral): $149/mo
- Brand-name semaglutide — Wegovy Pill Microdosing Plan: $149/mo
- Brand-name semaglutide — Wegovy Pen (injectable): $199/mo
- Brand-name semaglutide — Ozempic Pill (oral): $149/mo
- Brand-name semaglutide — Ozempic (injectable): $199/mo
- Brand-name tirzepatide — Zepbound vial: $299/mo
The medications Hims & Hers prescribes
Hims & Hers prescribes semaglutide and tirzepatide. Availability of both does not guarantee that switching is appropriate or that a new evaluation is unnecessary. The provider record lists access to FDA-approved brand products; confirm the exact medication and coverage with the clinician.
An oral or sublingual option is listed. Confirm the exact product: an FDA-approved oral medicine and a compounded oral formulation do not have the same approval status or supporting evidence.
Where Hims & Hers fits — and where it doesn't — for working moms
Right for you if…
- you want to start fast and async — no scheduled video visit to wedge between work and pickup.
- nationwide access matters — a move for work or family shouldn't interrupt care.
Not your best option if…
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you want frictionless cancellation and no prepay lock-in — the exit terms are the weak point here.
Trust, safety, and the fine print
Before enrolling with Hims & Hers, confirm the clinician, the dispensing pharmacy, and how to reach the care team between refills. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
Discuss pregnancy plans and breastfeeding with your clinician before starting or continuing treatment. Product-specific recommendations differ; this program review cannot establish that a medication is appropriate for you.
The bottom line
Choose Hims & Hers only when the ongoing cost and care arrangements fit your needs. Ask for the next charge, the cancellation deadline, and a contact for treatment questions before paying. Compare the same drug, supply period, and commitment across providers.
The bottom line for working moms
Best for: A mother who specifically wants FDA-approved brand medication with the manufacturer's own labeling, and who has done the arithmetic on a $149 monthly membership sitting on top of the drug price.
Alternatives to Hims & Hers
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete review directory.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- Visit Gala HealthRx-Readiness85100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included partner if you can live with a yearly plan and a pharmacy it doesn't name.
Keep comparing Hims & Hers
Head-to-head & alternatives
Hims & Hers, answered
- What does Hims or Hers actually cost per month?
- Take the number on the tile and add $149. Read live on 26 August 2026, every one of the ten GLP-1 listings carries the same footnote: "Price includes medication only, if prescribed. An active Hims Weight Loss Membership is required ($39 for the first month, auto-renews at $149/month thereafter). Membership is billed separately." So the Wegovy Pill at from $149 is about $298 a month ongoing, the Wegovy Pen at from $199 is about $348, and the Zepbound vial at from $299 is about $448. The $39 first month is a teaser, not a rate. If you compare the tile price against a flat-price compounded seller on this site you are not comparing the same thing.
- Is Hims still selling compounded semaglutide?
- No. The whole weight-loss catalog is now FDA-approved brand product: Wegovy in pill and pen, Zepbound as a vial and a KwikPen, Ozempic in pill and injection, Mounjaro, and Foundayo, the new oral orforglipron tablet. For a lot of readers that is the single best reason to consider it — the medication is the manufacturer's own, with the manufacturer's own labeling, rather than a compounded preparation from an unnamed pharmacy. It is also why the price sits where it does. The FDA warning letters this company holds are from September 2025 and concern the compounded business it has since left.
- Why is Zepbound listed at both $299 and $1,899 on the same page?
- We do not know, and neither does the page. Read live on 26 August 2026, the catalog carries a Zepbound Vial and a Zepbound KwikPen at from $299 a month, and separately a plain "Zepbound" listing and Mounjaro at a flat $1,899 a month. Nothing on the page explains the gap between the two Zepbound lines. Both figures are medication only and both still require the $149 membership. If you are shopping tirzepatide here, open both listings and read what each actually ships before you pick one — a $1,600 monthly difference is not a rounding error.
- Does Hims require a video visit, and does it work in my state?
- We cannot tell you first-hand, and that is worth saying plainly. Its FAQ page asks both questions — "Are video visits with a doctor required?" and "Are GLP-1s available in all states?" — but the answers sit inside collapsed accordions that are not part of the page text, so they were not readable in our pass. What the membership page does say is that you can be started "as soon as this week" and that care runs through 24/7 messaging with licensed providers plus monthly Care Team follow-ups, which reads like an asynchronous model. Confirm both before you pay the first month.
- What does the $149 membership actually buy?
- More than most membership fees on this list, which is the fairest thing to say about it. Its own membership page lists a personalized treatment plan, 24/7 messaging with licensed providers, monthly follow-ups with a care team, a smart scale for weight tracking (opt-in, shipped separately), a members' community, and discounts from HelloFresh, MyFitnessPal, Eight Sleep, Factor and Ladder. It also names in-house clinicians — Dr. Craig Primack on both sides and Dr. Shepherd on Hers. Whether that is worth $1,788 a year on top of medication is a real question, but it is not a fee for nothing.
- Hims has FDA warning letters. Does that matter now?
- It is worth knowing and it is worth putting in context. Two letters, both dated 9 September 2025, went to Hims & Hers Health, Inc. — one trading as Hims and naming hims.com, one to the same company trading as Hers. Both concern the compounded-semaglutide business, and the company has since moved its entire weight-loss catalog to FDA-approved brand product, which is the thing the letters were about. We keep the disclosure on the record rather than removing it, because a warning letter discloses rather than disqualifies and a reader searching for it should find it discussed here.
- Can I use insurance or an FSA at Hims?
- Its FAQ page carries both questions — "Is insurance required?" and "Do you take FSA and HSA?" — but as with the video-visit question, the answers are behind accordions and were not readable in our pass on 26 August 2026, so we are not going to guess at them. What the site states unambiguously is that the membership is required and billed separately, and that medication is not available without it. If you are counting on an FSA to carry part of this, get the answer in writing before the $39 month converts to $149.
Pricing, states and verification reflect Hims & Hers's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.